Aleniglipron or Placebo
GSBR-1290-06
Phase 2 small_molecule active
Quick answer
Aleniglipron or Placebo for Obesity, Overweight, or Chronic Weight Management is a Phase 2 program (small_molecule) at Structure Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Structure Therapeutics
- Indication
- Obesity, Overweight, or Chronic Weight Management
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active